Reports
Sale
Global Wound Debridement Market Size, Share, Report: By Product Type; By Methods: Autolytic, Enzymatic, Surgical, Mechanical, Others; By Purchase Outlook; By Type: Pressure Ulcers, Diabetic Foot Ulcers, Venous Leg Ulcers, Burn Wounds, Others; By End User: Hospitals, Home Healthcare, Others; Regional Analysis; Supplier Landscape; 2024-2032
Global Wound Debridement Market Outlook
The global wound debridement market size was valued at USD 3.70 billion in 2023, driven by the rising prevalence of diabetes across the globe. The market size is anticipated to grow at a CAGR of 5.6% during the forecast period of 2024-2032 to achieve a value of USD 6.04 billion by 2032.
Wound Debridement: Introduction
Debridement is a procedure to heal a wound in the skin and the removal of all hyperkeratotic (thickened skin or callus), infected, and nonviable (necrotic or dead) tissue, foreign debris, and residual material from dressings in wound debridement. Debridement could be performed surgically or by using some alternate methods, such as the use of special dressings and gels. Debridement is majorly performed for treating diabetic foot ulcers, which occur in at least 15% of patients with diabetes and precede 84% of all diabetes-related lower-leg amputations. The technique alters the environment by the removal of the dead tissues of the chronic wound, which ultimately promotes healing.
Global Wound Debridement Market Analysis
The growth of the market is driven by the increasing focus of biopharmaceutical companies on the development of new and innovative solutions in the wound debridement market. For example, an Investigational New Drug Application (IND) has been submitted to the US FDA earlier this year for a cutting edge enzymatic wound debriding agent, SN514 hydrogel by SERDA therapeutics. Clinical studies are expected to start in Q2 2024. The increasing number of research and clinical studies on testing advanced techniques to improve the performance and efficiency of the process is also contributing to the global wound debridement market growth.
A recent meta-analysis found that the use of ultrasound-supported wound debridement (USSD) in subjects with diabetic foot ulcer (DFU) resulted in comparatively higher wound healing rate with standard care and the placebo. The increasing technological development in the field of wound debridement is also expected to increase the market expansion. This includes the use of combinational topical oxygen therapy by Advanced Oxygen Therapy Inc. (AOTI), the global leader in non-invasive topical oxygen wound healing solutions in the treatment of diabetic foot ulcers (DFU) has been awarded as an A-grade recommendation by American Diabetes Association (ADA).
Global Wound Debridement Market Segmentations
Market Breakup by Product Type
- Gels
- Ointments and Creams
- Surgical Devices
- Medical Gauzes
- Ultrasonic Devices
- Others
Market Breakup by Methods
- Autolytic
- Enzymatic
- Surgical
- Mechanical
- Others
Market Breakup by Purchase Outlook
- Prescription
- Over the Counter
Market Breakup by Type
- Pressure Ulcers
- Diabetic Foot Ulcers
- Venous Leg Ulcers
- Burn Wounds
- Others
Market Breakup by End User
- Hospitals
- Home Healthcare
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Wound Debridement Market Overview
The increasing geriatric population across the globe is the major factor driving the market growth. The increasing prevalence among people is also contributing to the market growth as aged people are more susceptible to diabetes. The increasing demand and preference of minimally invasive surgical procedures is also driving the global wound debridement market growth.
Geographically, North America is expected to lead the market for the forecast period due to the presence of a big diabetic patient pool. The increasing approval by the US Food and Drug Administration is expected to contribute to the market growth. Key players are also focused on launching new and improved wound debridement products in North America, which is further expected to propel the market expansion and demand altogether.
Wound Debridement Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Coloplast Corp.
- Medline Industries
- Smith & Nephew
- ConvaTec Group PLC
- Integra LifeSciences
- B. Braun SE
- Molnlycke Health Care AB
- Brightwake Ltd.
- Lohmann & Rauscher
- 3M
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Methods |
|
| Breakup by Purchase Outlook |
|
| Breakup by Type |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Wound Debridement Market Overview
3.1 Global Wound Debridement Market Historical Value (2017-2023)
3.2 Global Wound Debridement Market Forecast Value (2024-2032)
4 Global Wound Debridement Market Landscape
4.1 Global Wound Debridement Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Wound Debridement Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Methods
4.2.3 Analysis by Applications
5 Global Wound Debridement Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Wound Debridement Market Segmentation
6.1 Global Wound Debridement Market by Product Type
6.1.1 Market Overview
6.1.2 Gels
6.1.3 Ointments and Creams
6.1.4 Surgical Devices
6.1.5 Medical Gauzes
6.1.6 Ultrasonic Devices
6.1.7 Others
6.2 Global Wound Debridement Market by Methods
6.2.1 Market Overview
6.2.2 Autolytic
6.2.3 Enzymatic
6.2.4 Surgical
6.2.5 Mechanical
6.2.6 Others
6.3 Global Wound Debridement Market by Purchase Outlook
6.3.1 Market Overview
6.3.2 Prescription
6.3.3 Over the Counter
6.4 Global Wound Debridement Market by Type
6.4.1 Market Overview
6.4.2 Pressure Ulcers
6.4.3 Diabetic Foot Ulcers
6.4.4 Venous Leg Ulcers
6.4.5 Burn Wounds
6.4.6 Others
6.5 Global Wound Debridement Market by End User
6.5.1 Market Overview
6.5.2 Hospitals
6.5.3 Home Healthcare
6.5.4 Others
6.6 Global Wound Debridement Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Wound Debridement Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Wound Debridement Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Wound Debridement Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Wound Debridement Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Wound Debridement Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Coloplast Corp.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisition
17.1.5 Certifications
17.2 Medline Industries
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisition
17.2.5 Certifications
17.3 Smith & Nephew
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisition
17.3.5 Certifications
17.4 ConvaTec Group PLC
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisition
17.4.5 Certifications
17.5 Integra LifeSciences
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisition
17.5.5 Certifications
17.6 B. Braun SE
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisition
17.6.5 Certifications
17.7 Molnlycke Health Care AB
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisition
17.7.5 Certifications
17.8 Brightwake Ltd.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisition
17.8.5 Certifications
17.9 Lohmann & Rauscher
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisition
17.9.5 Certifications
17.10 3M
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisition
17.10.5 Certifications
18 Global Wound Debridement Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 3.70 billion in 2023, driven by the increasing geriatric population.
The market is anticipated to grow at a CAGR of 5.6% during the forecast period of 2024-2032, likely to reach a market value of USD 6.04 billion by 2032.
The increasing prevalence of accidents, diabetes and ulcers among people across the globe is a major factor driving the market growth.
The increasing technological development to improve the performance and efficacy of wound debridement procedure is a major trend influencing the market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
Products available in the market are gels, ointments and creams, surgical devices, medical gauzes, and ultrasonic devices, among others.
Different methods in the market are autolytic, enzymatic, surgical, and mechanical, among others.
They can be purchased with prescriptions and over the counter.
The different types are pressure ulcers, diabetic foot ulcers, venous leg ulcers, and burn wounds, among others.
The end users in the market include hospitals and home healthcare, among others.
Key players involved in the market are Coloplast Corp., Medline Industries, Smith & Nephew, ConvaTec Group PLC, Integra LifeSciences, B. Braun SE, Molnlycke Health Care AB, Brightwake Ltd., Lohmann & Rauscher, and 3M.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER